MIRASOL: Mirvetuximab in Platinum Resistant Cancer
Mirvetuximab Soravtansine (MIRV) in platinum resistant ovarian cancer
Study Summaries
EORTC-55994: Neoadjuvant Chemotherapy Followed by Surgery vs. Chemoradiation in Locally Advanced Cervical Cancer
EORTC and the trial from TATA memorial. Is neoadjuvant chemotherapy and surgery an alternative to chemoradiation in locally advanced cervical cancer?
DUO-E: Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib in Advanced Endometrial Cancer
Does adding durvalumab (a PD-L1 inhibitor) and olaparib (a PARP inhibitor) to standard chemotherapy improve outcomes in advanced or recurrent endometrial cancer?
DESTINY-PanTumor02
Phase II study evaluating the role of HER2-directed ADC Trastuzumab deruxtecan (T-DxD)
OUTBACK Trial: Chemotherapy after Chemoradiation
OUTBACK trial